Sarah Spencer
Investor Relations Contact at VOR BIOPHARMA INC.
Sarah Spencer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VOR BIOPHARMA INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Career history of Sarah Spencer
Former positions of Sarah Spencer
| Companies | Position | Start | End |
|---|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Public Communications Contact | 31/03/2019 | 31/03/2021 |
| GSK PLC | Public Communications Contact | - | - |
Training of Sarah Spencer
| State University of New York at Buffalo | Undergraduate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 2 |
Operational
| Public Communications Contact | 3 |
| Undergraduate Degree | 1 |
| Investor Relations Contact | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Sarah Spencer
- Experience
